HEADER HYDROLASE 18-OCT-05 2C4F TITLE CRYSTAL STRUCTURE OF FACTOR VII.STF COMPLEXED WITH PD0297121 COMPND MOL_ID: 1; COMPND 2 MOLECULE: COAGULATION FACTOR VII PRECURSOR; COMPND 3 CHAIN: H; COMPND 4 FRAGMENT: FACTOR VII HEAVY CHAIN, RESIDUES 213-466; COMPND 5 SYNONYM: FACTOR VII, SERUM PROTHROMBIN CONVERSION ACCELERATOR, SPCA, COMPND 6 PROCONVERTIN, EPTACOG ALFA; COMPND 7 EC: 3.4.21.21; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: COAGULATION FACTOR VII PRECURSOR; COMPND 11 CHAIN: L; COMPND 12 FRAGMENT: FACTOR VII LIGHT CHAIN, RESIDUES 61-202; COMPND 13 SYNONYM: FACTOR VII, SERUM PROTHROMBIN CONVERSION ACCELERATOR, SPCA, COMPND 14 PROCONVERTIN, EPTACOG ALFA; COMPND 15 EC: 3.4.21.21; COMPND 16 ENGINEERED: YES; COMPND 17 MOL_ID: 3; COMPND 18 MOLECULE: TISSUE FACTOR PRECURSOR; COMPND 19 CHAIN: T; COMPND 20 FRAGMENT: FACTOR III, RESIDUES 38-112; COMPND 21 SYNONYM: TISSUE FACTOR, TF, COAGULATION FACTOR III THROMBOPLASTIN, COMPND 22 CD142 ANTIGEN; COMPND 23 ENGINEERED: YES; COMPND 24 MOL_ID: 4; COMPND 25 MOLECULE: TISSUE FACTOR PRECURSOR; COMPND 26 CHAIN: U; COMPND 27 FRAGMENT: FACTOR III, RESIDUES 123-242; COMPND 28 SYNONYM: TISSUE FACTOR, TF, COAGULATION FACTOR III THROMBOPLASTIN, COMPND 29 CD142 ANTIGEN; COMPND 30 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 MOL_ID: 2; SOURCE 6 SYNTHETIC: YES; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_TAXID: 9606; SOURCE 9 MOL_ID: 3; SOURCE 10 SYNTHETIC: YES; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 MOL_ID: 4; SOURCE 14 SYNTHETIC: YES; SOURCE 15 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 16 ORGANISM_TAXID: 9606 KEYWDS BLOOD COAGULATION, SERINE PROTEASE, EGF, EGF-LIKE DOMAIN, GLA, KEYWDS 2 RECEPTOR ENZYME, GLYCOPROTEIN, HYDROLASE, PROTEASE, HYDROXYLATION, KEYWDS 3 LIPOPROTEIN, PALMITATE, TRANSMEMBRANE EXPDTA X-RAY DIFFRACTION AUTHOR J.T.KOHRT,E.ZHANG REVDAT 6 29-JUL-20 2C4F 1 COMPND REMARK HETNAM LINK REVDAT 6 2 1 SITE REVDAT 5 22-MAY-19 2C4F 1 REMARK REVDAT 4 12-JUL-17 2C4F 1 REVDAT 3 24-FEB-09 2C4F 1 VERSN REVDAT 2 21-DEC-06 2C4F 1 ATOM REVDAT 1 18-OCT-06 2C4F 0 JRNL AUTH J.T.KOHRT,K.J.FILIPSKI,W.L.CODY,C.CAI,D.A.DUDLEY,C.A.V.HUIS, JRNL AUTH 2 J.A.WILLARDSEN,L.S.NARASIMHAN,E.ZHANG,S.T.RAPUNDALO, JRNL AUTH 3 K.SAIYA-CORK,R.J.LEADLEY,J.J.EDMUNDS JRNL TITL THE DISCOVERY OF FLUOROPYRIDINE-BASED INHIBITORS OF THE JRNL TITL 2 FACTOR VIIA/TF COMPLEX--PART 2 JRNL REF BIOORG.MED.CHEM.LETT. V. 16 1060 2006 JRNL REFN ISSN 0960-894X JRNL PMID 16289811 JRNL DOI 10.1016/J.BMCL.2005.10.076 REMARK 2 REMARK 2 RESOLUTION. 1.72 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.72 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 88.8 REMARK 3 NUMBER OF REFLECTIONS : 69287 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.229 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.500 REMARK 3 FREE R VALUE TEST SET COUNT : 3542 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4646 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 84 REMARK 3 SOLVENT ATOMS : 328 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.16000 REMARK 3 B22 (A**2) : 0.09400 REMARK 3 B33 (A**2) : 0.06600 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.330 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 44.99 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : LIG.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2C4F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 18-OCT-05. REMARK 100 THE DEPOSITION ID IS D_1290026024. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 74832 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.720 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 34.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.66 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.56 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 35.49650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 62.93000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.65100 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 62.93000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.49650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.65100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, L, T, U REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 FACTOR VII INITIATES THE EXTRINSIC PATHWAY OF BLOOD COAGULATION. REMARK 400 TISSUE FACTOR INITIATES BLOOD COAGULATION BY FORMING A COMPLEX WITH REMARK 400 FACTOR VII. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA L 1 REMARK 465 ASN L 2 REMARK 465 ALA L 3 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 HIS H 199 N - CA - C ANGL. DEV. = -17.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN H 60D 77.98 -102.06 REMARK 500 ASN H 63 40.16 -108.34 REMARK 500 HIS H 71 -57.65 -146.86 REMARK 500 THR H 129C -57.73 -120.45 REMARK 500 ASP H 170G 46.36 -98.20 REMARK 500 SER H 214 -67.62 -120.16 REMARK 500 CGU L 19 -71.45 -64.30 REMARK 500 ASP L 33 124.70 -171.15 REMARK 500 GLN L 100 -92.53 -120.47 REMARK 500 THR L 108 -139.85 -128.54 REMARK 500 PHE T 19 -3.81 73.69 REMARK 500 ASP T 66 93.14 -166.04 REMARK 500 ARG U 136 84.08 -170.53 REMARK 500 ASN U 137 67.85 70.12 REMARK 500 ASN U 138 14.87 57.32 REMARK 500 THR U 172 -147.11 -117.28 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA H 301 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU H 70 OE1 REMARK 620 2 ASP H 72 O 88.6 REMARK 620 3 GLU H 75 O 170.4 82.1 REMARK 620 4 GLU H 80 OE2 94.2 177.0 95.1 REMARK 620 5 HOH H 430 O 92.9 84.8 84.0 93.9 REMARK 620 6 HOH H 509 O 86.2 92.1 96.4 89.2 176.9 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA L 205 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CGU L 14 OE12 REMARK 620 2 CGU L 14 OE21 82.6 REMARK 620 3 CGU L 19 OE12 171.5 103.1 REMARK 620 4 CGU L 19 OE21 78.3 87.9 95.6 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA L 204 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CGU L 16 OE11 REMARK 620 2 CGU L 16 OE21 78.1 REMARK 620 3 CGU L 26 OE11 167.6 94.2 REMARK 620 4 CGU L 26 OE22 94.6 101.8 77.3 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA L 206 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CGU L 25 OE11 REMARK 620 2 CGU L 25 OE21 92.3 REMARK 620 3 CGU L 29 OE11 176.4 90.8 REMARK 620 4 CGU L 29 OE21 88.7 93.9 89.4 REMARK 620 5 HOH L 301 O 95.6 82.3 86.6 174.4 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA L 201 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP L 46 OD2 REMARK 620 2 GLY L 47 O 91.6 REMARK 620 3 GLN L 49 OE1 85.9 80.8 REMARK 620 4 ASP L 63 OD1 151.4 95.5 68.1 REMARK 620 5 ASP L 63 OD2 154.1 98.3 119.1 51.3 REMARK 620 6 GLN L 64 O 86.0 160.1 79.3 78.0 92.2 REMARK 620 7 HOH L 344 O 79.9 82.4 157.7 128.4 77.8 116.5 REMARK 620 N 1 2 3 4 5 6 REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "HA" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 8-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 9-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 700 THE SHEETS PRESENTED AS "HB" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 8-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 9-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AHW RELATED DB: PDB REMARK 900 A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN REMARK 900 INHIBITORY FAB (5G9) REMARK 900 RELATED ID: 1BOY RELATED DB: PDB REMARK 900 EXTRACELLULAR REGION OF HUMAN TISSUE FACTOR REMARK 900 RELATED ID: 1BF9 RELATED DB: PDB REMARK 900 N-TERMINAL EGF-LIKE DOMAIN FROM HUMAN FACTOR VII, NMR, 23 STRUCTURES REMARK 900 RELATED ID: 1TFH RELATED DB: PDB REMARK 900 EXTRACELLULAR DOMAIN OF HUMAN TISSUE FACTOR REMARK 900 RELATED ID: 1UJ3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMANIZED FAB FRAGMENT OF ANTI-TISSUE-FACTOR REMARK 900 ANTIBODY IN COMPLEX WITH TISSUE FACTOR REMARK 900 RELATED ID: 2HFT RELATED DB: PDB REMARK 900 MOL_ID: 1; MOLECULE: HUMAN TISSUE FACTOR; CHAIN: NULL; DOMAIN: REMARK 900 EXTRACELLULAR DOMAIN, RESIDUES 1 - 219; ENGINEERED: YES REMARK 900 RELATED ID: 1CVW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTIVE SITE-INHIBITED HUMAN COAGULATION FACTOR REMARK 900 VIIA (DES-GLA) REMARK 900 RELATED ID: 1DAN RELATED DB: PDB REMARK 900 COMPLEX OF ACTIVE SITE INHIBITED HUMAN BLOOD COAGULATION FACTOR REMARK 900 VIIA WITH HUMAN RECOMBINANT SOLUBLE TISSUE FACTOR REMARK 900 RELATED ID: 1DVA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE PEPTIDE EXOSITE REMARK 900 INHIBITOR E-76 AND COAGULATION FACTOR VIIA REMARK 900 RELATED ID: 1F7E RELATED DB: PDB REMARK 900 THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII, NMR, REMARK 900 20 STRUCTURES REMARK 900 RELATED ID: 1F7M RELATED DB: PDB REMARK 900 THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII, NMR, REMARK 900 MINIMIZED AVERAGE STRUCTURE REMARK 900 RELATED ID: 1FAK RELATED DB: PDB REMARK 900 HUMAN TISSUE FACTOR COMPLEXED WITH COAGULATION FACTOR VIIA REMARK 900 INHIBITED WITH A BPTI-MUTANT REMARK 900 RELATED ID: 1FF7 RELATED DB: PDB REMARK 900 THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII REMARK 900 (FUCOSYLATED AT SER-60), NMR, 20 STRUCTURES REMARK 900 RELATED ID: 1FFM RELATED DB: PDB REMARK 900 THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII REMARK 900 (FUCOSYLATED AT SER-60), NMR, MINIMIZED AVERAGE STRUCTURE REMARK 900 RELATED ID: 1J9C RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TISSUE FACTOR-FACTOR VIIA COMPLEX REMARK 900 RELATED ID: 1JPS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TISSUE FACTOR IN COMPLEX WITHHUMANIZED FAB REMARK 900 D3H44 REMARK 900 RELATED ID: 1JBU RELATED DB: PDB REMARK 900 COAGULATION FACTOR VII ZYMOGEN (EGF2/PROTEASE) IN COMPLEXWITH REMARK 900 INHIBITORY EXOSITE PEPTIDE A -183 REMARK 900 RELATED ID: 1KLI RELATED DB: PDB REMARK 900 COFACTOR-AND SUBSTRATE-ASSISTED ACTIVATION OF FACTOR VIIA REMARK 900 RELATED ID: 1KLJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF UNINHIBITED FACTOR VIIA REMARK 900 RELATED ID: 1NL8 RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX REMARK 900 RELATED ID: 1O5D RELATED DB: PDB REMARK 900 DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTSAT THE REMARK 900 S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190UPA) REMARK 900 RELATED ID: 1QFK RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN FACTOR VIIA AND ITS IMPLICATIONS FOR THE REMARK 900 TRIGGERING OF BLOOD COAGULATION REMARK 900 RELATED ID: 1W0Y RELATED DB: PDB REMARK 900 TF7A_3771 COMPLEX REMARK 900 RELATED ID: 1W2K RELATED DB: PDB REMARK 900 TF7A_4380 COMPLEX REMARK 900 RELATED ID: 1W7X RELATED DB: PDB REMARK 900 FACTOR7 - 413 COMPLEX REMARK 900 RELATED ID: 1W8B RELATED DB: PDB REMARK 900 FACTOR7 - 413 COMPLEX REMARK 900 RELATED ID: 1WQV RELATED DB: PDB REMARK 900 HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITHPROPYLSULFONAMIDE-D- REMARK 900 THR-MET-P- AMINOBENZAMIDINE REMARK 900 RELATED ID: 1YGC RELATED DB: PDB REMARK 900 SHORT FACTOR VIIA WITH A SMALL MOLECULE INHIBITOR REMARK 900 RELATED ID: 1Z6J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF FACTORVIIA/TISSUE FACTOR/ REMARK 900 PYRAZINONE INHIBITOR REMARK 900 RELATED ID: 2BZ6 RELATED DB: PDB REMARK 900 ORALLY AVAILABLE FACTOR7A INHIBITOR DBREF 2C4F H 16 257 UNP P08709 FA7_HUMAN 213 466 DBREF 2C4F L 1 142 UNP P08709 FA7_HUMAN 61 202 DBREF 2C4F T 6 80 UNP P13726 TF_HUMAN 38 112 DBREF 2C4F U 91 210 UNP P13726 TF_HUMAN 123 242 SEQRES 1 H 254 ILE VAL GLY GLY LYS VAL CYS PRO LYS GLY GLU CYS PRO SEQRES 2 H 254 TRP GLN VAL LEU LEU LEU VAL ASN GLY ALA GLN LEU CYS SEQRES 3 H 254 GLY GLY THR LEU ILE ASN THR ILE TRP VAL VAL SER ALA SEQRES 4 H 254 ALA HIS CYS PHE ASP LYS ILE LYS ASN TRP ARG ASN LEU SEQRES 5 H 254 ILE ALA VAL LEU GLY GLU HIS ASP LEU SER GLU HIS ASP SEQRES 6 H 254 GLY ASP GLU GLN SER ARG ARG VAL ALA GLN VAL ILE ILE SEQRES 7 H 254 PRO SER THR TYR VAL PRO GLY THR THR ASN HIS ASP ILE SEQRES 8 H 254 ALA LEU LEU ARG LEU HIS GLN PRO VAL VAL LEU THR ASP SEQRES 9 H 254 HIS VAL VAL PRO LEU CYS LEU PRO GLU ARG THR PHE SER SEQRES 10 H 254 GLU ARG THR LEU ALA PHE VAL ARG PHE SER LEU VAL SER SEQRES 11 H 254 GLY TRP GLY GLN LEU LEU ASP ARG GLY ALA THR ALA LEU SEQRES 12 H 254 GLU LEU MET VAL LEU ASN VAL PRO ARG LEU MET THR GLN SEQRES 13 H 254 ASP CYS LEU GLN GLN SER ARG LYS VAL GLY ASP SER PRO SEQRES 14 H 254 ASN ILE THR GLU TYR MET PHE CYS ALA GLY TYR SER ASP SEQRES 15 H 254 GLY SER LYS ASP SER CYS LYS GLY ASP SER GLY GLY PRO SEQRES 16 H 254 HIS ALA THR HIS TYR ARG GLY THR TRP TYR LEU THR GLY SEQRES 17 H 254 ILE VAL SER TRP GLY GLN GLY CYS ALA THR VAL GLY HIS SEQRES 18 H 254 PHE GLY VAL TYR THR ARG VAL SER GLN TYR ILE GLU TRP SEQRES 19 H 254 LEU GLN LYS LEU MET ARG SER GLU PRO ARG PRO GLY VAL SEQRES 20 H 254 LEU LEU ARG ALA PRO PHE PRO SEQRES 1 L 142 ALA ASN ALA PHE LEU CGU CGU LEU ARG PRO GLY SER LEU SEQRES 2 L 142 CGU ARG CGU CYS LYS CGU CGU GLN CYS SER PHE CGU CGU SEQRES 3 L 142 ALA ARG CGU ILE PHE LYS ASP ALA CGU ARG THR LYS LEU SEQRES 4 L 142 PHE TRP ILE SER TYR SER ASP GLY ASP GLN CYS ALA SER SEQRES 5 L 142 SER PRO CYS GLN ASN GLY GLY SER CYS LYS ASP GLN LEU SEQRES 6 L 142 GLN SER TYR ILE CYS PHE CYS LEU PRO ALA PHE GLU GLY SEQRES 7 L 142 ARG ASN CYS GLU THR HIS LYS ASP ASP GLN LEU ILE CYS SEQRES 8 L 142 VAL ASN GLU ASN GLY GLY CYS GLU GLN TYR CYS SER ASP SEQRES 9 L 142 HIS THR GLY THR LYS ARG SER CYS ARG CYS HIS GLU GLY SEQRES 10 L 142 TYR SER LEU LEU ALA ASP GLY VAL SER CYS THR PRO THR SEQRES 11 L 142 VAL GLU TYR PRO CYS GLY LYS ILE PRO ILE LEU GLU SEQRES 1 T 75 THR VAL ALA ALA TYR ASN LEU THR TRP LYS SER THR ASN SEQRES 2 T 75 PHE LYS THR ILE LEU GLU TRP GLU PRO LYS PRO VAL ASN SEQRES 3 T 75 GLN VAL TYR THR VAL GLN ILE SER THR LYS SER GLY ASP SEQRES 4 T 75 TRP LYS SER LYS CYS PHE TYR THR THR ASP THR GLU CYS SEQRES 5 T 75 ASP LEU THR ASP GLU ILE VAL LYS ASP VAL LYS GLN THR SEQRES 6 T 75 TYR LEU ALA ARG VAL PHE SER TYR PRO ALA SEQRES 1 U 116 GLU PRO LEU TYR GLU ASN SER PRO GLU PHE THR PRO TYR SEQRES 2 U 116 LEU GLU THR ASN LEU GLY GLN PRO THR ILE GLN SER PHE SEQRES 3 U 116 GLU GLN VAL GLY THR LYS VAL ASN VAL THR VAL GLU ASP SEQRES 4 U 116 GLU ARG THR LEU VAL ARG ARG ASN ASN THR PHE LEU SER SEQRES 5 U 116 LEU ARG ASP VAL PHE GLY LYS ASP LEU ILE TYR THR LEU SEQRES 6 U 116 TYR TYR TRP SER GLY LYS LYS THR ALA LYS THR ASN THR SEQRES 7 U 116 ASN GLU PHE LEU ILE ASP VAL ASP LYS GLY GLU ASN TYR SEQRES 8 U 116 CYS PHE SER VAL GLN ALA VAL ILE PRO SER ARG THR VAL SEQRES 9 U 116 ASN ARG LYS SER THR ASP SER PRO VAL GLU CYS MET MODRES 2C4F ASN U 124 ASN GLYCOSYLATION SITE MODRES 2C4F CGU L 6 GLU GAMMA-CARBOXY-GLUTAMIC ACID MODRES 2C4F CGU L 7 GLU GAMMA-CARBOXY-GLUTAMIC ACID MODRES 2C4F CGU L 14 GLU GAMMA-CARBOXY-GLUTAMIC ACID MODRES 2C4F CGU L 16 GLU GAMMA-CARBOXY-GLUTAMIC ACID MODRES 2C4F CGU L 19 GLU GAMMA-CARBOXY-GLUTAMIC ACID MODRES 2C4F CGU L 20 GLU GAMMA-CARBOXY-GLUTAMIC ACID MODRES 2C4F CGU L 25 GLU GAMMA-CARBOXY-GLUTAMIC ACID MODRES 2C4F CGU L 26 GLU GAMMA-CARBOXY-GLUTAMIC ACID MODRES 2C4F CGU L 29 GLU GAMMA-CARBOXY-GLUTAMIC ACID MODRES 2C4F CGU L 35 GLU GAMMA-CARBOXY-GLUTAMIC ACID HET CGU L 6 12 HET CGU L 7 12 HET CGU L 14 12 HET CGU L 16 12 HET CGU L 19 12 HET CGU L 20 12 HET CGU L 25 12 HET CGU L 26 12 HET CGU L 29 12 HET CGU L 35 12 HET CA H 301 1 HET GIL H 302 42 HET CA L 201 1 HET GLC L 202 12 HET FUC L 203 11 HET CA L 204 1 HET CA L 205 1 HET CA L 206 1 HET NAG U 301 14 HETNAM CGU GAMMA-CARBOXY-GLUTAMIC ACID HETNAM CA CALCIUM ION HETNAM GIL 2-{[6-{3-[AMINO(IMINO)METHYL]PHENOXY}-4- HETNAM 2 GIL (DIISOPROPYLAMINO)-3,5-DIFLUOROPYRIDIN-2-YL]OXY}-5- HETNAM 3 GIL [(ISOBUTYLAMINO)CARBONYL]BEN ZOIC ACID HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN GIL PD0297121 FORMUL 2 CGU 10(C6 H9 N O6) FORMUL 5 CA 5(CA 2+) FORMUL 6 GIL C30 H35 F2 N5 O5 FORMUL 8 GLC C6 H12 O6 FORMUL 9 FUC C6 H12 O5 FORMUL 13 NAG C8 H15 N O6 FORMUL 14 HOH *328(H2 O) HELIX 1 1 ALA H 55 ASP H 60 5 6 HELIX 2 2 GLU H 125 THR H 129C 1 8 HELIX 3 3 LEU H 129D VAL H 129G 5 4 HELIX 4 4 MET H 164 SER H 170B 1 9 HELIX 5 5 TYR H 234 MET H 242 1 9 HELIX 6 6 ARG L 36 SER L 45 1 10 HELIX 7 7 ASP L 48 SER L 53 5 6 HELIX 8 8 ASP L 86 GLN L 88 5 3 HELIX 9 9 ASN L 93 CYS L 98 5 6 HELIX 10 10 LEU T 59 VAL T 64 1 6 HELIX 11 11 THR U 101 THR U 106 1 6 HELIX 12 12 LEU U 143 GLY U 148 1 6 HELIX 13 13 LYS U 149 LEU U 151 5 3 SHEET 1 HA 9 LYS H 20 VAL H 21 0 SHEET 2 HA 9 MET H 156 LEU H 163 -1 O VAL H 157 N LYS H 20 SHEET 3 HA 9 MET H 180 ALA H 183 -1 O CYS H 182 N LEU H 163 SHEET 4 HA 9 GLY H 226 ARG H 230 -1 O GLY H 226 N ALA H 183 SHEET 5 HA 9 THR H 206 TRP H 215 -1 O ILE H 212 N THR H 229 SHEET 6 HA 9 PRO H 198 TYR H 203 -1 O HIS H 199 N THR H 210 SHEET 7 HA 9 PHE H 135 GLY H 140 -1 O LEU H 137 N ALA H 200 SHEET 8 HA 9 MET H 156 LEU H 163 1 O MET H 156 N GLY H 140 SHEET 9 HA 9 LYS H 20 VAL H 21 -1 O LYS H 20 N VAL H 157 SHEET 1 HB 9 GLN H 30 VAL H 35 0 SHEET 2 HB 9 ALA H 39 LEU H 46 -1 O ALA H 39 N VAL H 35 SHEET 3 HB 9 TRP H 51 SER H 54 -1 O VAL H 53 N THR H 45 SHEET 4 HB 9 ALA H 104 LEU H 108 -1 O ALA H 104 N SER H 54 SHEET 5 HB 9 GLN H 81 PRO H 91 1 N ALA H 86 O ARG H 107 SHEET 6 HB 9 LEU H 64 LEU H 68 -1 O LEU H 64 N VAL H 85 SHEET 7 HB 9 GLN H 30 VAL H 35 -1 O LEU H 32 N VAL H 67 SHEET 8 HB 9 ALA H 39 LEU H 46 -1 O ALA H 39 N VAL H 35 SHEET 9 HB 9 GLN H 30 VAL H 35 -1 O VAL H 31 N GLY H 44 SHEET 1 LA 2 SER L 60 GLN L 64 0 SHEET 2 LA 2 SER L 67 PHE L 71 -1 O SER L 67 N GLN L 64 SHEET 1 LB 2 PHE L 76 GLU L 77 0 SHEET 2 LB 2 THR L 83 HIS L 84 -1 O THR L 83 N GLU L 77 SHEET 1 LC 2 TYR L 101 SER L 103 0 SHEET 2 LC 2 SER L 111 ARG L 113 -1 O SER L 111 N SER L 103 SHEET 1 LD 2 TYR L 118 LEU L 120 0 SHEET 2 LD 2 CYS L 127 PRO L 129 -1 O THR L 128 N SER L 119 SHEET 1 TA 3 TYR T 10 THR T 17 0 SHEET 2 TA 3 LYS T 20 GLU T 26 -1 O LYS T 20 N THR T 17 SHEET 3 TA 3 GLU T 56 ASP T 58 -1 O CYS T 57 N LEU T 23 SHEET 1 TB 4 LYS T 46 THR T 52 0 SHEET 2 TB 4 GLN T 32 THR T 40 -1 O TYR T 34 N THR T 52 SHEET 3 TB 4 TYR T 71 PRO T 79 -1 O LEU T 72 N SER T 39 SHEET 4 TB 4 LEU U 93 ASN U 96 -1 O LEU U 93 N SER T 77 SHEET 1 UA 3 ILE U 113 VAL U 119 0 SHEET 2 UA 3 LYS U 122 VAL U 127 -1 O LYS U 122 N VAL U 119 SHEET 3 UA 3 GLU U 174 ASP U 178 -1 O PHE U 175 N VAL U 125 SHEET 1 UB 2 ARG U 131 ARG U 135 0 SHEET 2 UB 2 PHE U 140 SER U 142 -1 O LEU U 141 N THR U 132 SHEET 1 UC 4 LYS U 166 THR U 170 0 SHEET 2 UC 4 ILE U 152 TRP U 158 -1 O TYR U 153 N THR U 170 SHEET 3 UC 4 CYS U 186 VAL U 192 -1 O CYS U 186 N TRP U 158 SHEET 4 UC 4 GLU U 208 CYS U 209 -1 O GLU U 208 N PHE U 187 SSBOND 1 CYS H 22 CYS H 27 1555 1555 2.04 SSBOND 2 CYS H 42 CYS H 58 1555 1555 2.04 SSBOND 3 CYS H 122 CYS L 135 1555 1555 2.03 SSBOND 4 CYS H 168 CYS H 182 1555 1555 2.03 SSBOND 5 CYS H 191 CYS H 220 1555 1555 2.02 SSBOND 6 CYS L 17 CYS L 22 1555 1555 2.03 SSBOND 7 CYS L 50 CYS L 61 1555 1555 2.03 SSBOND 8 CYS L 55 CYS L 70 1555 1555 2.03 SSBOND 9 CYS L 72 CYS L 81 1555 1555 2.04 SSBOND 10 CYS L 91 CYS L 102 1555 1555 2.03 SSBOND 11 CYS L 98 CYS L 112 1555 1555 2.04 SSBOND 12 CYS L 114 CYS L 127 1555 1555 2.03 SSBOND 13 CYS T 49 CYS T 57 1555 1555 2.04 SSBOND 14 CYS U 186 CYS U 209 1555 1555 2.03 LINK C LEU L 5 N CGU L 6 1555 1555 1.34 LINK C CGU L 6 N CGU L 7 1555 1555 1.34 LINK C CGU L 7 N LEU L 8 1555 1555 1.38 LINK C LEU L 13 N CGU L 14 1555 1555 1.35 LINK C CGU L 14 N ARG L 15 1555 1555 1.38 LINK C ARG L 15 N CGU L 16 1555 1555 1.35 LINK C CGU L 16 N CYS L 17 1555 1555 1.38 LINK C LYS L 18 N CGU L 19 1555 1555 1.34 LINK C CGU L 19 N CGU L 20 1555 1555 1.34 LINK C CGU L 20 N GLN L 21 1555 1555 1.38 LINK C PHE L 24 N CGU L 25 1555 1555 1.34 LINK C CGU L 25 N CGU L 26 1555 1555 1.34 LINK C CGU L 26 N ALA L 27 1555 1555 1.37 LINK C ARG L 28 N CGU L 29 1555 1555 1.34 LINK C CGU L 29 N ILE L 30 1555 1555 1.38 LINK C ALA L 34 N CGU L 35 1555 1555 1.34 LINK C CGU L 35 N ARG L 36 1555 1555 1.38 LINK ND2 ASN U 124 C1 NAG U 301 1555 1555 1.45 LINK OE1 GLU H 70 CA CA H 301 1555 1555 2.21 LINK O ASP H 72 CA CA H 301 1555 1555 2.24 LINK O GLU H 75 CA CA H 301 1555 1555 2.10 LINK OE2 GLU H 80 CA CA H 301 1555 1555 2.11 LINK CA CA H 301 O HOH H 430 1555 1555 2.19 LINK CA CA H 301 O HOH H 509 1555 1555 2.15 LINK OE12 CGU L 14 CA CA L 205 1555 1555 2.65 LINK OE21 CGU L 14 CA CA L 205 1555 1555 2.46 LINK OE11 CGU L 16 CA CA L 204 1555 1555 2.14 LINK OE21 CGU L 16 CA CA L 204 1555 1555 2.12 LINK OE12 CGU L 19 CA CA L 205 1555 1555 2.38 LINK OE21 CGU L 19 CA CA L 205 1555 1555 2.25 LINK OE11 CGU L 25 CA CA L 206 1555 1555 2.11 LINK OE21 CGU L 25 CA CA L 206 1555 1555 2.23 LINK OE11 CGU L 26 CA CA L 204 1555 1555 2.12 LINK OE22 CGU L 26 CA CA L 204 1555 1555 2.23 LINK OE11 CGU L 29 CA CA L 206 1555 1555 2.29 LINK OE21 CGU L 29 CA CA L 206 1555 1555 2.20 LINK OD2 ASP L 46 CA CA L 201 1555 1555 2.22 LINK O GLY L 47 CA CA L 201 1555 1555 2.32 LINK OE1 GLN L 49 CA CA L 201 1555 1555 2.36 LINK OD1 ASP L 63 CA CA L 201 1555 1555 2.64 LINK OD2 ASP L 63 CA CA L 201 1555 1555 2.40 LINK O GLN L 64 CA CA L 201 1555 1555 2.36 LINK CA CA L 201 O HOH L 344 1555 1555 2.38 LINK CA CA L 206 O HOH L 301 1555 4556 2.30 CISPEP 1 PHE H 256 PRO H 257 0 0.12 CISPEP 2 GLU T 26 PRO T 27 0 0.07 CRYST1 70.993 81.302 125.860 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014086 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012300 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007945 0.00000